Counterfeit and adulterated prescription drugs in the supply distribution chain pose a significant risk to patient safety. On November 27, 2013, President Obama enacted the Drug Supply Chain Security Act (DSCSA), which amends the Prescription Drug Marketing Act of 1987.1 The amended Act creates a uniform, national standard for tracing prescription drug products throughout the supply distribution chain with critical staged requirements going into effect soon that will challenge conventional technologies and logistics capabilities.
Please see full publication below for more information.